Coming Soon

Astrazeneca UK Limited

Registration Number 03674842

Company Overview

Company Name
Astrazeneca UK Limited
Registration Number
03674842
Founded
26 November 1998
Age
25 years
Industry Region
East of England
Registered Postcode
CB2 0AA

Online Profile

false

Special Flags

Public Funding Received

Public Funding for Astrazeneca UK Limited

2023-06-01
Maximising Efficiency of Liquid Phase Oligo Synthesis (MELOS)
Collaborative R&D
2022-09-01
101057668 — ETERNAL — HORIZON-HLTH-2021-IND-07
EU-Funded
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-04-01
A coordinated strategy to scale-up advanced therapies for patient in Manchester
Centres
2021-03-01
Accelerating the development of biotherapeutics for subcutaneous delivery
Study
2020-06-01
Use of OrbiSIMS to identify impurities on drug crystal surfaces and characterise surface chemical structures on spray-dried pharmaceutical formulations
Collaborative R&D
2020-03-01
Digital Design Accelerator Platform to Connect Active Material Design to Product Performance
Collaborative R&D
2019-09-01
University of Warwick and AstraZeneca UK Limited
Knowledge Transfer Partnership
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2019-08-01
Genomics Main Phase - Early Diagnosis
Collaborative R&D
2017-10-01
Combining Organ-on-Chip Models of Fatty Liver with Computational Biology to Enable Drug Re-purposing
Collaborative R&D
2016-03-01
Virtual Fish Ecotoxicology Laboratory
Collaborative R&D
2015-10-01
University of Bradford and AstraZeneca UK Limited
Knowledge Transfer Partnership
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-07-01
Accelerating paediatric formulation development through smart design and predictive science
Collaborative R&D
2014-06-01
Digital Design of Drug Products
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2014-05-01
Formulation for targeted delivery of novel therapies for oncology
Collaborative R&D
2011-04-01
The University of York And AstraZeneca UK Limited
Knowledge Transfer Partnership

Get notified when we’re launching.

Want fast, powerful sales prospecting for UK companies? Signup below to find out when we're live.